As a result, in the initial stages of anti-androgen drug resistance there is decreased inflammatory response but down regulation of tumor suppressor targets of miR-146a, BCORL1 [135] and RNASEL [136], which may not be detected in fully developed CRPC. The gene discussed is BCORL1; the disease is neoplasm.